Chao Xiao

Statistics

Publications

Citations

273

H-Index

Active since

2013

Affiliations

Shanghai Sixth People's Hospital(Current)

Shanghai Jiao Tong University

Chao Xiao is an author at Shanghai Sixth People's Hospital specializing in myelodysplastic syndromes, life sciences, and myelodysplastic syndrome therapy.

Publications per year

2013–2023

Publications

<i>TP53</i> mutations predict decitabine‐induced complete responses in patients with myelodysplastic syndromes

Chunkang Chang, Youshan Zhao, Feng Xu et al. · British Journal of Haematology · 2016 · 77 citations · Full text

Life Sciences, Molecular Genetics, Oncology +16

Genetic landscape of recurrent ASXL1, U2AF1, SF3B1, SRSF2, and EZH2 mutations in 304 Chinese patients with myelodysplastic syndromes

Lingyun Wu, Luxi Song, Lan Xu et al. · Tumor Biology · 2015 · 49 citations

Life Sciences, Genetics, Molecular Genetics +11

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes

Feng Xu, Lingyun Wu, Chunkang Chang et al. · Nature Communications · 2015 · 42 citations · Full text

Medicine, Genetics, Molecular Genetics +14

High expression of the human equilibrative nucleoside transporter 1 gene predicts a good response to decitabine in patients with myelodysplastic syndrome

Lingyun Wu, Wenhui Shi, Xiao Li et al. · Journal of Translational Medicine · 2016 · 23 citations · Full text

Medicine, Hematology, Pharmacology +13

Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes.

Zheng Zhang, Qi He, Tao Ying et al. · PubMed · 2017 · 22 citations

Life Sciences, Immunology, Pharmacology +17

1–5 of 9